ETF Exchange > IBB ETF
IBB - ETF Fact Sheet
iShares Biotechnology ETF - USD
Fund Identification
Ticker
IBB
ISIN
US4642875565
Main Metrics
Price
$189.74Expense Ratio
0.44%AuM
$9,392.07MTracking Difference
-0.55%Ratings
Trackinsight rating
★★★★★Official Investment Strategy
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
IBB's historical prices, performance, and flows
1m returns
11%
1m flows
$386M
* Net total returns
All data as of 17 July 2026
The ETF Exchange is brought to you by
With data and analysis by
See all IBB data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
IBB's characteristics
Manager
Manager statistics
1787 funds, $6,330.41Bn in AUM
Benchmark
ICE Biotechnology Index (TR) - USD
Replication method
Direct (Physical)
Asset class
Equity
Dividend policy
Distributing
IBB's exposure
Countries
USA
86.14%
Other
13.86%
Sectors
Healthcare
99.87%
Top 5 holdings
Gilead Sciences, Inc.
7.42%
Vertex Pharmaceuticals, Inc.
7.40%
Amgen, Inc.
7.13%
Regeneron Pharmaceuticals, Inc.
5.69%
Alnylam Pharmaceuticals, Inc.
3.61%
Total holdings
244
Total weight of top 5
31.26%
